Cargando…
Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update()
OBJECTIVE: To update the prevalence of atherosclerotic cardiovascular disease (ASCVD) in the United States (US) and re-evaluate lipid-lowering therapies (LLT) utilization and low-density lipoprotein cholesterol (LDL-C) goal attainment among ASCVD patients after proprotein convertase subtilisin/kexin...
Autores principales: | Gu, Jing, Sanchez, Robert, Chauhan, Ankita, Fazio, Sergio, Wong, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968014/ https://www.ncbi.nlm.nih.gov/pubmed/35368909 http://dx.doi.org/10.1016/j.ajpc.2022.100336 |
Ejemplares similares
-
Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
por: Klimchak, Alexa C., et al.
Publicado: (2020) -
Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
por: Lis, Anna, et al.
Publicado: (2023) -
Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom
por: Reynolds, Timothy Mark, et al.
Publicado: (2021) -
Attaining Goals Through Partnerships
por: Ramirez, Julio J.
Publicado: (2003) -
Factors associated with lipid goal attainment among acute coronary syndrome patients
por: Mohd-Zulkefli, Siti-Zainora, et al.
Publicado: (2016)